A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Simple Search

You could also try: episodic (5), intermittent (36), sporadic (4)

Everolimus v1.1

Description
Chemotherapy Protocol RENAL CELL EVEROLIMUS This protocol may require funding Regimen Renal Cell - Everolimus Indication Advanced renal cell carcinoma that has
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Renal-cell/Everolimus-v1.1.pdf

Everolimus Ver 1

Description
Chemotherapy Protocol PANCREATIC NEUROENDOCRINE CARCINOMA EVEROLIMUS This protocol may require funding Regimen PNET - Everolimus Indication The first or second line treatment
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Endocrinecancer/Everolimus-Ver-1.pdf

Everolimus-Exemestane

Description
Regimen Chemotherapy Protocol BREAST CANCER EVEROLIMUS and EXEMESTANE • Breast Cancer – Everolimus-Exemestane Indication • The first or second line treatment of post
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Everolimus-Exemestane.pdf

Everolimus-Lenvatinib

Description
Chemotherapy Protocol RENAL CELL EVEROLIMUS and LENVATINIB Regimen • Renal Cell – Everolimus-Lenvatinib Indication • Confirmed histological diagnosis of inoperable locally advanced or
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Renal-cell/Everolimus-Lenvatinib.pdf

Azacitidine Oral

Description
Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA -AZACITADINE (ORAL) Regimen • AML – AZACITADINE (ORAL) Indication Oral azacitidine as maintenance therapy in newly diagnosed AML
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/Azacitidine-Oral.pdf

Capecitabine-Lapatinib

Description
Chemotherapy Protocol BREAST CANCER CAPECITABINE-LAPATINIB This protocol may require funding Regimen • Breast Cancer – Capecitabine-Lapatinib Indication • Treatment of locally advanced
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/CapecitabineLapatinib.pdf

Dabrafenib Trametinib Ver1

Description
Chemotherapy Protocol SKIN CANCER DABRAFENIB-TRAMETINIB Regimen  Skin – Dabrafenib-Trametinib Indication  The combination of dabrafenib and trametinib is recommended as an
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/SkinDabrafenibTrametinibVer1.pdf

IPD-Dexamethasone-Isatuximab-Pomalidomide

Description
Chemotherapy Protocol Myeloma Isatuximab-Dexamethasone (40)-Pomalidomide Regimen • Myeloma – Isatuximab-Dexamethasone (40
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/IPD-Dexamethasone-Isatuximab-Pomalidomide.pdf

Regorafenib

Description
Chemotherapy Protocol Gastro-Intestinal Stromal Tumour Regorafenib Regimen • GIST – Regorafenib Indication • Regorafenib is recommended for histologically confirmed metastatic or unresectable gastronintestinal
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/Regorafenib.pdf

Dexamethasone(40)-Pomalidomide

Description
Regimen Chemotherapy Protocol Myeloma Dexamethasone (40)-Pomalidomide • Myeloma – Dexamethasone (40)-Pomalidomide Indication • Pomalidomide, in
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Dexamethasone-40-Pomalidomide.pdf
1 to 10 of 187
Previous 1 2 3 4 5 … Next